Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Longtec 10mg modified-release tablets
0407020ADBEABAF
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 31,239 |
|
Longtec 20mg modified-release tablets
0407020ADBEACAG
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 24,121 |
|
Longtec 5mg modified-release tablets
0407020ADBEAAAK
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 22,439 |
|
Longtec 30mg modified-release tablets
0407020ADBEAHAR
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 13,208 |
|
Longtec 40mg modified-release tablets
0407020ADBEADAH
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 13,032 |
|
Longtec 15mg modified-release tablets
0407020ADBEAGAS
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 8,751 |
|
Longtec 60mg modified-release tablets
0407020ADBEAIAQ
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 4,917 |
|
Longtec 80mg modified-release tablets
0407020ADBEAEAI
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 4,283 |
|
Longtec 120mg modified-release tablets
0407020ADBEAFAP
|
Longtec | Oxycodone hydrochloride | Central Nervous System | 1,387 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.